Shannon K. Clark

Representative Matters

• Represented Novartis in Novartis v. Breckenridge, West-Ward, and Par (Zortress® (everolimus) for kidney and liver transplantation); Novartis v. West-Ward (Afinitor® (everolimus) for renal cell carcinoma and pancreatic neuroendocrine tumors); Novartis v. Par (Afinitor® (everolimus) for breast cancer)
• Represented Regeneron in Regeneron v. Merus (VelocImmune® transgenic mice)
• Represented Bausch Health in Bausch Health v. Sun (Xifaxan® (rifaximin) for travelers’ diarrhea); Bausch Health v. Sandoz (Xifaxan® (rifaximin) to treat irritable bowel syndrome with diarrhea); Valeant v. Actavis (Xifaxan® (rifaximin) to treat irritable bowel syndrome with diarrhea and hepatic encephalopathy)
• Represented UCB in UCB v. Mallinckrodt and UCB v. Teva (Metadate® CD (methylphenidate) for attention deficit hyperactivity disorder)

Representative Clients

• Gilead
• UCB
• Regeneron
• Novartis
• Bausch Health

Education

• J.D. magna cum laude Seton Hall University School of Law 2011
• B.S. Biology cum laude Birmingham-Southern College 2008

Bar Admissions

• Virginia
• New York
• U.S. Patent and Trademark Office

Court Admissions

• U.S. Court of Appeals for the Federal Circuit

• The Best Lawyers in America, Ones to Watch, 2021 – 2022, 2024 – 2025

Pro Bono

• Secured compassionate release of a federal inmate during the COVID-19 pandemic

Volunteerism

• Member, Junior League